Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease
Public ClinicalTrials.gov record NCT06293365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL Pre-filled Syringe With 1 mL Pre-filled Syringe in Adult Participants With Autoimmune Disease
Study identification
- NCT ID
- NCT06293365
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 155 participants
Conditions and interventions
Interventions
- VAY736 1ml PFS Biological
- VAY736 2 ml PFS Biological
- VAY736 2ml AI Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1, 2024
- Primary completion
- Jun 4, 2025
- Completion
- Jan 15, 2029
- Last update posted
- May 11, 2026
2024 – 2029
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group Llc | Anniston | Alabama | 36207 | — |
| Providence Medical Foundation | Fullerton | California | 92835 | — |
| Advanced Medical Research | La Palma | California | 90623 | — |
| Conquest Research | Winter Park | Florida | 32789 | — |
| Parris and Associates Rheumatology | Lawrenceville | Georgia | 30044 | — |
| Indiana Univ School of Dentistry | Indianapolis | Indiana | 46202 | — |
| Ochsner Health System | Baton Rouge | Louisiana | 70809 | — |
| Ahmed Arif Medical Research Center | Grand Blanc | Michigan | 48439 | — |
| Paramount Med Rsrch and Consult LLC | Middleburg Heights | Ohio | 44130 | — |
| RAO Research LLC | Oklahoma City | Oklahoma | 73116 | — |
| Altoona Center for Clin Res | Duncansville | Pennsylvania | 16635 | — |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | — |
| Shelby Research LLC | Memphis | Tennessee | 38119 | — |
| Novel Research LLC | Bellaire | Texas | 77401 | — |
| Southwest Rheum Rsrch LLC | Mesquite | Texas | 75150 | — |
| Uni of Texas Health Science Center | San Antonio | Texas | 78229 | — |
| Advanced Rheumatology of Houston | Spring | Texas | 77382 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
Recently updated Rheumatoid Arthritis trials
Other public records listing Rheumatoid Arthritis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07137598: A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors) Recruiting
- NCT04817969: Persona Ti-Nidium Post-Market Clinical Follow-up Active, not recruiting
- NCT07620392: An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis Recruiting
- NCT05936970: Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD Active, not recruiting
- NCT07704580: Phase 1b/2 Study of IV Sarilumab in Adult With RA Recruiting
- NCT07293871: Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06293365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06293365 live on ClinicalTrials.gov.